A potential new treatment in development for multiple sclerosis created at QIMR Berghofer Medical Research Institute has secured a deal worth up to $63 million. …
QIMR Berghofer attracts support for potential multiple sclerosis treatment
December 16, 2021 Australian Biotech
Latest Video
New Stories
-
GSK therapy becomes first biologic subsidised for Australians with uncontrolled COPD
September 1, 2026 - -
Those who ask questions and critique the process are treated as people who question and critique the process
September 1, 2026 - - Latest News -
New Zealand to fund flu vaccines for all children under five from 2027
September 1, 2026 - - Latest News -
Trust and collaboration take centre stage as Australia confronts widening vaccine gaps
September 1, 2026 - - Latest News -
Six Australian infectious disease ventures share $10.48 million in Biointelect funding round
August 31, 2026 - - Latest News -
BLS posts record earnings as overseas expansion accelerates
August 31, 2026 - - Latest News -
Private hospitals sustain 230,000 jobs despite $756 million loss
August 31, 2026 - - Other Health